Table 4.
Oncological Outcomes
| Variable | Total Cohort |
|---|---|
| N = 706 | |
| Median follow-up duration, years (IQR) | 3.42 (1.95, 4.62) |
| 2-year LR, % (95% CI) | 4.95 (3.50–6.75) |
| Central pelvis | 1.75 (0.96–2.95) |
| Lateral pelvis | 1.46 (0.75–2.58) |
| Anastomosis | 0.30 (0.06–1.01) |
| Multifocal | 1.45 (0.75–2.58) |
| 3-year LR, % (95% CI) | 6.82 (5.08–8.89) |
| Central pelvis | 2.53 (1.53–3.93) |
| Lateral pelvis | 2.07 (1.19–3.37) |
| Anastomosis | 0.45 (0.13–1.25) |
| Multifocal | 1.76 (0.96–2.97) |
| Pattern of LR, n (%) | |
| Unifocal | 42/56 (75.0) |
| Multifocal | 14/56 (25.0) |
| Time to LR (years), median (IQR) | 1.35 (0.71, 2.59) |
| 3-year RFS, % (95% CI) | 73.3 (70.0–76.7) |
| 3-year OS, % (95% CI) | 91.6 (89.5–93.7) |
CI indicates confidence interval; IQR, interquartile range; LR, local recurrence; OS, overall survival; RFS, relapse-free survival.